Alpha Cognition Launches ZUNVEYL, First Oral Alzheimer’s Drug Approved by FDA in a Decade
32-Person Sales Team Targets $2 Billion Long-Term Care Market as Company Marks Major Milestone in Alzheimer’s Treatment Alpha Cognition (ACOG) ...
32-Person Sales Team Targets $2 Billion Long-Term Care Market as Company Marks Major Milestone in Alzheimer’s Treatment Alpha Cognition (ACOG) ...
Deal Would Be Google Parent's Largest Ever, Amid Rising Enterprise Demand for Cloud Security Post-CrowdStrike Outage Alphabet Inc. (GOOGL) the ...
Shares Trade Sideways After 40% Decline; Technical Support at $85 and Resistance at $100 in Focus Palantir Technologies (PLTR) shares ...
Free FSD Trial in China Fails to Calm Investor Concerns as JPMorgan Slashes Q1 Delivery Forecast Tesla (TSLA) shares plunged ...
Retailer Faces Competitive Pressures and Internal Challenges Ulta Beauty (ULTA) delivered stronger-than-expected fourth-quarter results, but weak guidance for 2025 sent ...
Magnificent Seven and High-Growth Tech Names Struggle Amid Volatility Magnificent Seven and High-Growth Tech Names Struggle Amid Volatility The stock ...
Chip Giants Nvidia, AMD, and TSMC Reportedly Eye Intel’s Manufacturing Unit Intel (INTC) saw its stock climb 3% on Wednesday ...
A Century-Long Public Market Presence Ends as Industry Pressures Mount Walgreens Boots Alliance (WBA) has sealed a $10 billion deal ...
Retail giant struggles with cautious consumers, declining sales, and economic headwinds Macy’s (M) has joined the ranks of major retailers ...
E-commerce giant sees double-digit growth in users and sales, buoyed by government incentives JD.com (JD) outperformed market forecasts for quarterly ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?